StonvexLoading…
StonvexStonvexStonvexCore line items from UI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $2.34B | $1.55B | $733.77M | $2.57B |
Operating Income | $845.44M | $554.62M | $261.72M | $836.28M |
Net Income | $675.40M | $233.61M | $207.88M | $711.92M |
EPS (Diluted) | $11.15 | $7.29 | $3.43 | $11.76 |
Total Assets | $1.72B | $1.61B | $1.49B | $1.47B |
Total Liabilities | $513.28M | $592.63M | $661.83M | $798.19M |
Cash & Equivalents | $368.66M | $302.82M | $177.19M | $149.73M |
Free Cash Flow OCF − CapEx | $615.79M | $453.57M | $193.29M | $627.44M |
Shares Outstanding | 60.52M | 60.50M | 60.50M | 60.49M |